Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?

por Fonsatti, Ester, Di Giacomo, Anna Maria, Maio, Michele
Publicado 2004

From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma

por Simonetti, Elena, Cutarella, Serena, Valente, Monica, Sani, Tommaso, Ravara, Matteo, Maio, Michele, Di Giacomo, Anna Maria
Publicado 2023

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation

por Maio, Michele, Lahn, Michael, Di Giacomo, Anna Maria, Covre, Alessia, Calabrò, Luana, Ibrahim, Ramy, Fox, Bernard
Publicado 2021

Successful Targeting of CTLA-4 in a Melanoma Clinical Case: A Long-Term “One Stop Therapeutic Shop”

por Colucci, Maura, D’Alonzo, Vincenzo, Santangelo, Federica, Miracco, Clelia, Valente, Monica, Maio, Michele, Di Giacomo, Anna Maria
Publicado 2022

Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID

por Cusi, Maria Grazia, Di Giacomo, Anna Maria, Anichini, Gabriele, Gori Savellini, Gianni, Terrosi, Chiara, Gandolfo, Claudia, Maio, Michele
Publicado 2023

Immunotherapy of brain metastases: breaking a “dogma”

por Di Giacomo, Anna Maria, Valente, Monica, Cerase, Alfonso, Lofiego, Maria Fortunata, Piazzini, Francesca, Calabrò, Luana, Gambale, Elisabetta, Covre, Alessia, Maio, Michele
Publicado 2019

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

por Maccalli, Cristina, Nicolay, Hugues, Capocefalo, Filippo, Fonsatti, Ester, Chiarucci, Carla, Cutaia, Ornella, Giannarelli, Diana, Parmiani, Giorgio, Di Giacomo, Anna Maria, Maio, Michele
Publicado 2013

Challenges in lung cancer therapy during the COVID-19 pandemic

por Calabrò, Luana, Peters, Solange, Soria, Jean-Charles, Di Giacomo, Anna Maria, Barlesi, Fabrice, Covre, Alessia, Altomonte, Maresa, Vegni, Virginia, Gridelli, Cesare, Reck, Martin, Rizvi, Naiyer, Maio, Michele
Publicado 2020

Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy

por Lofiego, Maria Fortunata, Cannito, Sara, Fazio, Carolina, Piazzini, Francesca, Cutaia, Ornella, Solmonese, Laura, Marzani, Francesco, Chiarucci, Carla, Di Giacomo, Anna Maria, Calabrò, Luana, Coral, Sandra, Maio, Michele, Covre, Alessia
Publicado 2021

Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study

por Calabrò, Luana, Rossi, Giulia, Morra, Aldo, Rosati, Claudio, Cutaia, Ornella, Daffinà, Maria Grazia, Altomonte, Maresa, Di Giacomo, Anna Maria, Casula, Milena, Fazio, Carolina, Palmieri, Giuseppe, Giannarelli, Diana, Covre, Alessia, Maio, Michele
Publicado 2021

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy

por Fazio, Carolina, Covre, Alessia, Cutaia, Ornella, Lofiego, Maria Fortunata, Tunici, Patrizia, Chiarucci, Carla, Cannito, Sara, Giacobini, Gianluca, Lowder, James N., Ferraldeschi, Roberta, Taverna, Pietro, Di Giacomo, Anna Maria, Coral, Sandra, Maio, Michele
Publicado 2018

Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival

por Chiarucci, Carla, Cannito, Sara, Daffinà, Maria Grazia, Amato, Giovanni, Giacobini, Gianluca, Cutaia, Ornella, Lofiego, Maria Fortunata, Fazio, Carolina, Giannarelli, Diana, Danielli, Riccardo, Di Giacomo, Anna Maria, Coral, Sandra, Calabrò, Luana, Maio, Michele, Covre, Alessia
Publicado 2020

The cost of unresectable stage III or stage IV melanoma in Italy

por Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publicado 2012

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

por Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publicado 2013

A novel microRNA signature for the detection of melanoma by liquid biopsy

por Sabato, Claudia, Noviello, Teresa Maria Rosaria, Covre, Alessia, Coral, Sandra, Caruso, Francesca Pia, Besharat, Zein Mersini, Splendiani, Elena, Masuelli, Laura, Battistelli, Cecilia, Vacca, Alessandra, Catanzaro, Giuseppina, Po, Agnese, Anichini, Andrea, Maio, Michele, Ceccarelli, Michele, Di Giacomo, Anna Maria, Ferretti, Elisabetta
Publicado 2022

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

por Queirolo, Paola, Spagnolo, Francesco, Ascierto, Paolo Antonio, Simeone, Ester, Marchetti, Paolo, Scoppola, Alessandro, Del Vecchio, Michele, Di Guardo, Lorenza, Maio, Michele, Di Giacomo, Anna Maria, Antonuzzo, Andrea, Cognetti, Francesco, Ferraresi, Virginia, Ridolfi, Laura, Guidoboni, Massimo, Guida, Michele, Pigozzo, Jacopo, Chiarion Sileni, Vanna
Publicado 2014

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

por Ferrucci, Pier Francesco, Di Giacomo, Anna Maria, Del Vecchio, Michele, Atkinson, Victoria, Schmidt, Henrik, Schachter, Jacob, Queirolo, Paola, Long, Georgina V, Stephens, Rosalie, Svane, Inge Marie, Lotem, Michal, Abu-Amna, Mahmoud, Gasal, Eduard, Ghori, Razi, Diede, Scott J, Croydon, Elizabeth S, Ribas, Antoni, Ascierto, Paolo Antonio
Publicado 2020

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial

por Noviello, Teresa Maria Rosaria, Di Giacomo, Anna Maria, Caruso, Francesca Pia, Covre, Alessia, Mortarini, Roberta, Scala, Giovanni, Costa, Maria Claudia, Coral, Sandra, Fridman, Wolf H., Sautès-Fridman, Catherine, Brich, Silvia, Pruneri, Giancarlo, Simonetti, Elena, Lofiego, Maria Fortunata, Tufano, Rossella, Bedognetti, Davide, Anichini, Andrea, Maio, Michele, Ceccarelli, Michele
Publicado 2023

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advan...

por Guida, Michele, Bartolomeo, Nicola, Quaresmini, Davide, Quaglino, Pietro, Madonna, Gabriele, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Minisini, Alessandro Marco, Tucci, Marco, Spagnolo, Francesco, Occelli, Marcella, Ridolfi, Laura, Queirolo, Paola, De Risi, Ivana, Valente, Monica, Sciacovelli, Angela Monica, Chiarion Sileni, Vanna, Ascierto, Paolo Antonio, Stigliano, Lucia, Strippoli, Sabino
Publicado 2022

Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients

por Huber, Veronica, Di Guardo, Lorenza, Lalli, Luca, Giardiello, Daniele, Cova, Agata, Squarcina, Paola, Frati, Paola, Di Giacomo, Anna Maria, Pilla, Lorenzo, Tazzari, Marcella, Camisaschi, Chiara, Arienti, Flavio, Castelli, Chiara, Rodolfo, Monica, Beretta, Valeria, Di Nicola, Massimo, Maio, Michele, Del Vecchio, Michele, de Braud, Filippo, Mariani, Luigi, Rivoltini, Licia
Publicado 2021